GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Semantic nitpicking:

>…there does seem to be a dose-ranging aspect to the trial.<

Three doses of ATryn are being tested but I would not characterize this study as dose-ranging, a term generally used for phase-1 trials where the maximum dose has not yet been established. Dose finding, as opposed to dose ranging, means that a goal of the study is to pick the best dose(s) to take into phase-3.